✦ LIBER ✦

Improved outcome from substituting methotrexate with epirubicin: Results from a randomised comparison of CMF versus CEF in patients with primary breast cancer

✍ Scribed by Bent Ejlertsen; Henning T. Mouridsen; Maj-Britt Jensen; Jørn Andersen; Søren Cold; Per Edlund; Marianne Ewertz; Brita B. Jensen; Claus Kamby; Bo Nordenskjold; Jonas Bergh

Book ID: 116429259
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 229 KB
Volume: 43
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2007.01.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant anthracycline in breast cancer.

Adjuvant anthracycline in breast cancer. Improved outcome in premenopausal patients following substitution of methotrexate in the CMF Combination with epirubicin

✍ Henning T. Mouridsen; Jørn Andersen; Michael Andersson; Per Dombernowsky; Bent E 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Dose-intensified epirubicin versus stand

Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) – The German Adjuvant Breast Cancer Group

✍ Wolfgang Eiermann; Erika Graf; Beyhan Ataseven; Bettina Conrad; Jörn Hilfrich; H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 665 KB

P90 Tandem versus single high dose chemo

P90 Tandem versus single high dose chemotherapy (HDC)with haematopoietic stem cell support in patients with chemosensitive metastatic breast cancer (MBC): outcome parameters - results from a randomised multicenter phase III trial

✍ S. Mohrmann; N. Kroeger; M. Frick; G. Schuett; B. Metzner; Y. Ko; E. Berdel; O. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views